Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Schmallenberg vaccine approved
UK farmers first to gain access to vaccine

The Veterinary Medicines Directorate (VMD) has announced that UK farmers will be the first in the EU to gain access to a vaccine against schmallenberg (SBV) virus.

Pharmaceutical company MSD Animal Health has been issued a licence to provide the vaccine known as "Bovilis SBV".

When Bovilis SBV becomes available this summer, cattle and sheep will be able to have the vaccination before they become pregnant, protecting the foetus from damage caused by SBV.

News of the vaccine has been welcomed by the British Veterinary Association (BVA). President Peter Jones, said: "Given the serious worry that this new disease has caused and the significant losses that individual farmers have faced, the news that a vaccine is now available should be warmly welcomed.
 
"Farmers can now plan with good veterinary advice how, where and when to use the vaccine to protect their animals and their offspring."

News of the vaccine was reported in the media in February, when the VMD confirmed that MSD had applied for provisional marketing authorisation at the end of August 2012.

The VMD is usually unable to comment on applications it has received but the exception was made due to the high levels of industry and media interest in a possible vaccine.

Bovilis SBV will be available across the UK from summer 2013.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.